McNeely Hare & War LLP
General
Cases70
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechMech Eng, ManufSemicond., Optic
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
02/21/25 | CLERK'S QUALITY CONTROL MESSAGE - The [2] Corporate Disclosure Statement submitted by William Hare on 2/20/2025 contains an improper signature. Only the filing user is permitted to sign electronically filed documents with an s/. PLEASE RESUBMIT THE DOCUMENT WITH A PROPER ELECTRONIC SIGNATURE. This submission will remain on the docket unless otherwise ordered by the court. (jjc) (Entered: 02/21/2025) | |
01/28/25 | TEXT ORDER - Per counsel's request (ECF [124] ), the telephone conference set for February 3, 2025 before Magistrate Judge Leda D. Wettre is adjourned to March 6, 2025 at 2:30 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 102 387 269#. So Ordered by Magistrate Judge Leda D. Wettre on 1/28/2025. (rn) (Entered: 01/28/2025) | |
09/16/24 | Corporate Disclosure Statement by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (LIZZA, CHARLES) (Entered: 09/16/2024) | |
09/16/24 | COMPLAINT against ALKEM LABORATORIES LTD., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LTD., HETERO USA INC., HIKMA PHARMACEUTICALS USA INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15667470) , Related Case Selected, filed by AXSOME THERAPEUTICS, INC., AXSOME MALTA LTD.. (Attachments: # [1] Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 09/16/2024) | |
09/09/24 | TEXT ORDER: The Court will hold a Zoom conference on 10/10/24 at 10:30am to address Plaintiff counsel's motion to withdraw (ECF No. [48] ). Plaintiff's current counsel shall inform Plaintiff that its representative must attend the next video conference. Plaintiff's counsel shall send Plaintiff a copy of this Order, as well as the Zoom connection information to the conference, when it becomes available, and shall file a Certification of Service. The Court notes that, if replacement counsel for Plaintiff files a substitution of counsel in advance of the next conference, no appearances will be necessary.. So Ordered by Magistrate Judge Cathy L. Waldor on 9/9/24. (tjg, ) (Entered: 09/09/2024) | |
09/09/24 | Minute Entry for proceedings held before Magistrate Judge Cathy L. Waldor: Status Conference held on 9/9/2024. (tjg, ) (Entered: 09/09/2024) | |
08/21/24 | Corporate Disclosure Statement by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (LIZZA, CHARLES) (Entered: 08/21/2024) | |
08/21/24 | COMPLAINT against AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15607265), Related Case Selected, filed by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # 1 Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 08/21/2024) | |
07/09/24 | WAIVER OF SERVICE Returned Executed by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. AUROBINDO PHARMA LIMITED waiver sent on 7/8/2024, answer due 9/6/2024. (LIZZA, CHARLES) (Entered: 07/09/2024) | |
07/09/24 | WAIVER OF SERVICE Returned Executed by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. AUROBINDO PHARMA USA, INC. waiver sent on 7/8/2024, answer due 9/6/2024. (LIZZA, CHARLES) (Entered: 07/09/2024) |